Medical Developments International (ASX:MVP) Shares Up 0.4%

Medical Developments International Ltd (ASX:MVP)’s stock price shot up 0.4% during mid-day trading on Monday . The company traded as high as A$4.67 ($3.31) and last traded at A$4.67 ($3.31), 4,832 shares traded hands during mid-day trading. The stock had previously closed at A$4.65 ($3.30).

The firm’s fifty day moving average is A$5.43. The company has a market capitalization of $305.96 million and a price-to-earnings ratio of 291.88. The company has a debt-to-equity ratio of 0.41, a quick ratio of 3.81 and a current ratio of 4.21.

The firm also recently declared a Final dividend, which will be paid on Friday, October 4th. Stockholders of record on Friday, October 4th will be issued a dividend of $0.02 per share. The ex-dividend date is Tuesday, September 3rd. This represents a dividend yield of 0.42%. Medical Developments International’s dividend payout ratio (DPR) is presently 250.00%.



About Medical Developments International (ASX:MVP)

Medical Developments International Limited manufactures and distributes pharmaceutical drugs, and medical and veterinary equipment in Australia and internationally. The company operates in three segments: Pharmaceuticals, Medical Devices, and Veterinary Products. It offers asthma and COPD pressurized metered dose inhalers, as well as masks and peak flow meters for asthma management; Penthrox, a prescription only medicine for acute pain; medical devices; and various veterinary anesthetic machines to veterinarians.

Featured Article: What are retained earnings?

Receive News & Ratings for Medical Developments International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Developments International and related companies with MarketBeat.com's FREE daily email newsletter.